IL6 and pulmonary hypertension: Furthermore, an investigation conducted by Yang et al. (2022), utilized ROC analysis to identify serum hsCRP and IL-6 as autonomous risk factors for chronic obstructive pulmonary disease in conjunction with pulmonary hypertension.